Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
1,042 trades
$10.3T in total
Open-market sales
1,304 trades
$2.5B in total
Insiders filing
572 insiders
Last 7 days
Trade type
CG OncologyCGON
Open-market buy10b5-1 plan06/2506/29371,085 sh$66.87$24,814,453.95+24.5%
CG OncologyCGON
Open-market sale10b5-1 plan06/2406/255,000 sh$70.00$350,000−100.0%
CG OncologyCGON
Open-market sale10b5-1 plan06/2206/235,000 sh$65.00$325,000−100.0%
Director
CG OncologyCGON
Open-market sale10b5-1 plan06/1506/161,964 sh2 trades$60.12avg.$118,075.68−100.0%
CG OncologyCGON
Open-market sale10b5-1 plan06/0406/051,000 sh$54.50$54,500−100.0%
CG OncologyCGON
Open-market sale10b5-1 plan04/1704/2015,600 sh$73.01$1,138,956−100.0%
Director
CG OncologyCGON
Open-market sale10b5-1 plan03/1603/171,964 sh2 trades$63.50avg.$124,714−100.0%
Director
CG OncologyCGON
Open-market sale10b5-1 plan01/0901/1311,145 sh2 trades$52.47avg.$584,798.73−100.0%
CG OncologyCGON
Open-market sale10b5-1 plan25/11/1725/11/181,000 sh$41.43$41,430−100.0%
CG OncologyCGON
Open-market sale10b5-1 plan25/10/1325/10/151,000 sh$43.25$43,250−100.0%
CG OncologyCGON
Open-market sale10b5-1 plan25/10/0925/10/105,903 sh$43.99$259,672.97−100.0%
CG OncologyCGON
Open-market sale10b5-1 plan25/09/3025/10/015,000 sh$40.09$200,450−100.0%
CG OncologyCGON
Open-market sale10b5-1 plan25/09/2925/09/3012,755 sh$39.19$499,868.45−100.0%
Director
CG OncologyCGON
Open-market sale10b5-1 plan25/09/18–25/09/1925/09/2222,686 sh2 trades$39.01avg.$884,909.38−100.0%
CG OncologyCGON
Open-market sale10b5-1 plan25/09/1525/09/161,000 sh$35.10$35,100−100.0%
CG OncologyCGON
Open-market buy10b5-1 plan25/09/1125/09/151,515,151 sh$33.00$49,999,983No record
Director
CG OncologyCGON
Open-market sale10b5-1 plan25/09/0525/09/0827,015 sh4 trades$31.53avg.$851,797.1−100.0%
CG OncologyCGON
Open-market sale10b5-1 plan25/09/0325/09/041,000 sh$28.00$28,000−100.0%
Director
CG OncologyCGON
Open-market sale10b5-1 plan25/09/0325/09/04100,000 sh4 trades$27.80avg.$2,779,542.2−3.3%
CG OncologyCGON
Open-market sale10b5-1 plan25/07/1725/07/182,000 sh$28.00$56,000−100.0%